0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global In-Vitro Cancer Diagnostics Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-31C1668
Home | Market Reports | Health| Health Conditions| Cancer
Global In Vitro Cancer Diagnostics Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global In-Vitro Cancer Diagnostics Market Research Report 2024

Code: QYRE-Auto-31C1668
Report
January 2024
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

In-Vitro Cancer Diagnostics Market

In-vitro cancer diagnostics are medical tests and assays used to detect and diagnose cancer using patient samples, such as blood, tissue, or urine.
The global In-Vitro Cancer Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for in-vitro cancer diagnostics is driven by the growing burden of cancer and the need for early and accurate cancer detection. The market's growth is also influenced by the development of novel biomarkers and advanced diagnostic technologies, leading to improved sensitivity and specificity of cancer tests.
This report aims to provide a comprehensive presentation of the global market for In-Vitro Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Vitro Cancer Diagnostics.

Report Scope

The In-Vitro Cancer Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In-Vitro Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-Vitro Cancer Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of In-Vitro Cancer Diagnostics Market Report

Report Metric Details
Report Name In-Vitro Cancer Diagnostics Market
Segment by Type
  • Instruments
  • Reagents and Kits
Segment by Application
  • Laboratories
  • Hospitals
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company MDx Health Quest Diagnostics, R-Biopharm AG, Signature Diagnostics, Siemens Healthcare, Randox Laboratories, Epigenomics AG, Beckman Coulter, Abbott Laboratories, Burning Rock, Novogene, Geneseeq, Amoy Diagnostics Co.,Ltd., Daan Gene, Fosun Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of In-Vitro Cancer Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the In-Vitro Cancer Diagnostics Market report?

Ans: The main players in the In-Vitro Cancer Diagnostics Market are MDx Health Quest Diagnostics, R-Biopharm AG, Signature Diagnostics, Siemens Healthcare, Randox Laboratories, Epigenomics AG, Beckman Coulter, Abbott Laboratories, Burning Rock, Novogene, Geneseeq, Amoy Diagnostics Co.,Ltd., Daan Gene, Fosun Pharma

What are the Application segmentation covered in the In-Vitro Cancer Diagnostics Market report?

Ans: The Applications covered in the In-Vitro Cancer Diagnostics Market report are Laboratories, Hospitals, Others

What are the Type segmentation covered in the In-Vitro Cancer Diagnostics Market report?

Ans: The Types covered in the In-Vitro Cancer Diagnostics Market report are Instruments, Reagents and Kits

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Instruments
1.2.3 Reagents and Kits
1.3 Market by Application
1.3.1 Global In-Vitro Cancer Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Laboratories
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-Vitro Cancer Diagnostics Market Perspective (2019-2030)
2.2 In-Vitro Cancer Diagnostics Growth Trends by Region
2.2.1 Global In-Vitro Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 In-Vitro Cancer Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 In-Vitro Cancer Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 In-Vitro Cancer Diagnostics Market Dynamics
2.3.1 In-Vitro Cancer Diagnostics Industry Trends
2.3.2 In-Vitro Cancer Diagnostics Market Drivers
2.3.3 In-Vitro Cancer Diagnostics Market Challenges
2.3.4 In-Vitro Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-Vitro Cancer Diagnostics Players by Revenue
3.1.1 Global Top In-Vitro Cancer Diagnostics Players by Revenue (2019-2024)
3.1.2 Global In-Vitro Cancer Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global In-Vitro Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In-Vitro Cancer Diagnostics Revenue
3.4 Global In-Vitro Cancer Diagnostics Market Concentration Ratio
3.4.1 Global In-Vitro Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Cancer Diagnostics Revenue in 2023
3.5 In-Vitro Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players In-Vitro Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into In-Vitro Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Cancer Diagnostics Breakdown Data by Type
4.1 Global In-Vitro Cancer Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global In-Vitro Cancer Diagnostics Forecasted Market Size by Type (2025-2030)
5 In-Vitro Cancer Diagnostics Breakdown Data by Application
5.1 Global In-Vitro Cancer Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global In-Vitro Cancer Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America In-Vitro Cancer Diagnostics Market Size (2019-2030)
6.2 North America In-Vitro Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In-Vitro Cancer Diagnostics Market Size by Country (2019-2024)
6.4 North America In-Vitro Cancer Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-Vitro Cancer Diagnostics Market Size (2019-2030)
7.2 Europe In-Vitro Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In-Vitro Cancer Diagnostics Market Size by Country (2019-2024)
7.4 Europe In-Vitro Cancer Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Cancer Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific In-Vitro Cancer Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-Vitro Cancer Diagnostics Market Size (2019-2030)
9.2 Latin America In-Vitro Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In-Vitro Cancer Diagnostics Market Size by Country (2019-2024)
9.4 Latin America In-Vitro Cancer Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Cancer Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa In-Vitro Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MDx Health Quest Diagnostics
11.1.1 MDx Health Quest Diagnostics Company Detail
11.1.2 MDx Health Quest Diagnostics Business Overview
11.1.3 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Introduction
11.1.4 MDx Health Quest Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.1.5 MDx Health Quest Diagnostics Recent Development
11.2 R-Biopharm AG
11.2.1 R-Biopharm AG Company Detail
11.2.2 R-Biopharm AG Business Overview
11.2.3 R-Biopharm AG In-Vitro Cancer Diagnostics Introduction
11.2.4 R-Biopharm AG Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.2.5 R-Biopharm AG Recent Development
11.3 Signature Diagnostics
11.3.1 Signature Diagnostics Company Detail
11.3.2 Signature Diagnostics Business Overview
11.3.3 Signature Diagnostics In-Vitro Cancer Diagnostics Introduction
11.3.4 Signature Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.3.5 Signature Diagnostics Recent Development
11.4 Siemens Healthcare
11.4.1 Siemens Healthcare Company Detail
11.4.2 Siemens Healthcare Business Overview
11.4.3 Siemens Healthcare In-Vitro Cancer Diagnostics Introduction
11.4.4 Siemens Healthcare Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.4.5 Siemens Healthcare Recent Development
11.5 Randox Laboratories
11.5.1 Randox Laboratories Company Detail
11.5.2 Randox Laboratories Business Overview
11.5.3 Randox Laboratories In-Vitro Cancer Diagnostics Introduction
11.5.4 Randox Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.5.5 Randox Laboratories Recent Development
11.6 Epigenomics AG
11.6.1 Epigenomics AG Company Detail
11.6.2 Epigenomics AG Business Overview
11.6.3 Epigenomics AG In-Vitro Cancer Diagnostics Introduction
11.6.4 Epigenomics AG Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.6.5 Epigenomics AG Recent Development
11.7 Beckman Coulter
11.7.1 Beckman Coulter Company Detail
11.7.2 Beckman Coulter Business Overview
11.7.3 Beckman Coulter In-Vitro Cancer Diagnostics Introduction
11.7.4 Beckman Coulter Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.7.5 Beckman Coulter Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Detail
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories In-Vitro Cancer Diagnostics Introduction
11.8.4 Abbott Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.8.5 Abbott Laboratories Recent Development
11.9 Burning Rock
11.9.1 Burning Rock Company Detail
11.9.2 Burning Rock Business Overview
11.9.3 Burning Rock In-Vitro Cancer Diagnostics Introduction
11.9.4 Burning Rock Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.9.5 Burning Rock Recent Development
11.10 Novogene
11.10.1 Novogene Company Detail
11.10.2 Novogene Business Overview
11.10.3 Novogene In-Vitro Cancer Diagnostics Introduction
11.10.4 Novogene Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.10.5 Novogene Recent Development
11.11 Geneseeq
11.11.1 Geneseeq Company Detail
11.11.2 Geneseeq Business Overview
11.11.3 Geneseeq In-Vitro Cancer Diagnostics Introduction
11.11.4 Geneseeq Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.11.5 Geneseeq Recent Development
11.12 Amoy Diagnostics Co.,Ltd.
11.12.1 Amoy Diagnostics Co.,Ltd. Company Detail
11.12.2 Amoy Diagnostics Co.,Ltd. Business Overview
11.12.3 Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Introduction
11.12.4 Amoy Diagnostics Co.,Ltd. Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.12.5 Amoy Diagnostics Co.,Ltd. Recent Development
11.13 Daan Gene
11.13.1 Daan Gene Company Detail
11.13.2 Daan Gene Business Overview
11.13.3 Daan Gene In-Vitro Cancer Diagnostics Introduction
11.13.4 Daan Gene Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.13.5 Daan Gene Recent Development
11.14 Fosun Pharma
11.14.1 Fosun Pharma Company Detail
11.14.2 Fosun Pharma Business Overview
11.14.3 Fosun Pharma In-Vitro Cancer Diagnostics Introduction
11.14.4 Fosun Pharma Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.14.5 Fosun Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Instruments
    Table 3. Key Players of Reagents and Kits
    Table 4. Global In-Vitro Cancer Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global In-Vitro Cancer Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global In-Vitro Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global In-Vitro Cancer Diagnostics Market Share by Region (2019-2024)
    Table 8. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global In-Vitro Cancer Diagnostics Market Share by Region (2025-2030)
    Table 10. In-Vitro Cancer Diagnostics Market Trends
    Table 11. In-Vitro Cancer Diagnostics Market Drivers
    Table 12. In-Vitro Cancer Diagnostics Market Challenges
    Table 13. In-Vitro Cancer Diagnostics Market Restraints
    Table 14. Global In-Vitro Cancer Diagnostics Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global In-Vitro Cancer Diagnostics Market Share by Players (2019-2024)
    Table 16. Global Top In-Vitro Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Cancer Diagnostics as of 2023)
    Table 17. Ranking of Global Top In-Vitro Cancer Diagnostics Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by In-Vitro Cancer Diagnostics Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players In-Vitro Cancer Diagnostics Product Solution and Service
    Table 21. Date of Enter into In-Vitro Cancer Diagnostics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global In-Vitro Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2019-2024)
    Table 25. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2025-2030)
    Table 27. Global In-Vitro Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global In-Vitro Cancer Diagnostics Revenue Market Share by Application (2019-2024)
    Table 29. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global In-Vitro Cancer Diagnostics Revenue Market Share by Application (2025-2030)
    Table 31. North America In-Vitro Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America In-Vitro Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America In-Vitro Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe In-Vitro Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe In-Vitro Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe In-Vitro Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific In-Vitro Cancer Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America In-Vitro Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America In-Vitro Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America In-Vitro Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa In-Vitro Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 46. MDx Health Quest Diagnostics Company Detail
    Table 47. MDx Health Quest Diagnostics Business Overview
    Table 48. MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Product
    Table 49. MDx Health Quest Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
    Table 50. MDx Health Quest Diagnostics Recent Development
    Table 51. R-Biopharm AG Company Detail
    Table 52. R-Biopharm AG Business Overview
    Table 53. R-Biopharm AG In-Vitro Cancer Diagnostics Product
    Table 54. R-Biopharm AG Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
    Table 55. R-Biopharm AG Recent Development
    Table 56. Signature Diagnostics Company Detail
    Table 57. Signature Diagnostics Business Overview
    Table 58. Signature Diagnostics In-Vitro Cancer Diagnostics Product
    Table 59. Signature Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
    Table 60. Signature Diagnostics Recent Development
    Table 61. Siemens Healthcare Company Detail
    Table 62. Siemens Healthcare Business Overview
    Table 63. Siemens Healthcare In-Vitro Cancer Diagnostics Product
    Table 64. Siemens Healthcare Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
    Table 65. Siemens Healthcare Recent Development
    Table 66. Randox Laboratories Company Detail
    Table 67. Randox Laboratories Business Overview
    Table 68. Randox Laboratories In-Vitro Cancer Diagnostics Product
    Table 69. Randox Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
    Table 70. Randox Laboratories Recent Development
    Table 71. Epigenomics AG Company Detail
    Table 72. Epigenomics AG Business Overview
    Table 73. Epigenomics AG In-Vitro Cancer Diagnostics Product
    Table 74. Epigenomics AG Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
    Table 75. Epigenomics AG Recent Development
    Table 76. Beckman Coulter Company Detail
    Table 77. Beckman Coulter Business Overview
    Table 78. Beckman Coulter In-Vitro Cancer Diagnostics Product
    Table 79. Beckman Coulter Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
    Table 80. Beckman Coulter Recent Development
    Table 81. Abbott Laboratories Company Detail
    Table 82. Abbott Laboratories Business Overview
    Table 83. Abbott Laboratories In-Vitro Cancer Diagnostics Product
    Table 84. Abbott Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
    Table 85. Abbott Laboratories Recent Development
    Table 86. Burning Rock Company Detail
    Table 87. Burning Rock Business Overview
    Table 88. Burning Rock In-Vitro Cancer Diagnostics Product
    Table 89. Burning Rock Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
    Table 90. Burning Rock Recent Development
    Table 91. Novogene Company Detail
    Table 92. Novogene Business Overview
    Table 93. Novogene In-Vitro Cancer Diagnostics Product
    Table 94. Novogene Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
    Table 95. Novogene Recent Development
    Table 96. Geneseeq Company Detail
    Table 97. Geneseeq Business Overview
    Table 98. Geneseeq In-Vitro Cancer Diagnostics Product
    Table 99. Geneseeq Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
    Table 100. Geneseeq Recent Development
    Table 101. Amoy Diagnostics Co.,Ltd. Company Detail
    Table 102. Amoy Diagnostics Co.,Ltd. Business Overview
    Table 103. Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Product
    Table 104. Amoy Diagnostics Co.,Ltd. Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
    Table 105. Amoy Diagnostics Co.,Ltd. Recent Development
    Table 106. Daan Gene Company Detail
    Table 107. Daan Gene Business Overview
    Table 108. Daan Gene In-Vitro Cancer Diagnostics Product
    Table 109. Daan Gene Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
    Table 110. Daan Gene Recent Development
    Table 111. Fosun Pharma Company Detail
    Table 112. Fosun Pharma Business Overview
    Table 113. Fosun Pharma In-Vitro Cancer Diagnostics Product
    Table 114. Fosun Pharma Revenue in In-Vitro Cancer Diagnostics Business (2019-2024) & (US$ Million)
    Table 115. Fosun Pharma Recent Development
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global In-Vitro Cancer Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global In-Vitro Cancer Diagnostics Market Share by Type: 2023 VS 2030
    Figure 3. Instruments Features
    Figure 4. Reagents and Kits Features
    Figure 5. Global In-Vitro Cancer Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global In-Vitro Cancer Diagnostics Market Share by Application: 2023 VS 2030
    Figure 7. Laboratories Case Studies
    Figure 8. Hospitals Case Studies
    Figure 9. Others Case Studies
    Figure 10. In-Vitro Cancer Diagnostics Report Years Considered
    Figure 11. Global In-Vitro Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global In-Vitro Cancer Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global In-Vitro Cancer Diagnostics Market Share by Region: 2023 VS 2030
    Figure 14. Global In-Vitro Cancer Diagnostics Market Share by Players in 2023
    Figure 15. Global Top In-Vitro Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Cancer Diagnostics as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by In-Vitro Cancer Diagnostics Revenue in 2023
    Figure 17. North America In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America In-Vitro Cancer Diagnostics Market Share by Country (2019-2030)
    Figure 19. United States In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Canada In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe In-Vitro Cancer Diagnostics Market Share by Country (2019-2030)
    Figure 23. Germany In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. France In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. U.K. In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Italy In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Russia In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Nordic Countries In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific In-Vitro Cancer Diagnostics Market Share by Region (2019-2030)
    Figure 31. China In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Japan In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. South Korea In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Southeast Asia In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. India In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Australia In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America In-Vitro Cancer Diagnostics Market Share by Country (2019-2030)
    Figure 39. Mexico In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Brazil In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Country (2019-2030)
    Figure 43. Turkey In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Saudi Arabia In-Vitro Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. MDx Health Quest Diagnostics Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
    Figure 46. R-Biopharm AG Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
    Figure 47. Signature Diagnostics Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
    Figure 48. Siemens Healthcare Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
    Figure 49. Randox Laboratories Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
    Figure 50. Epigenomics AG Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
    Figure 51. Beckman Coulter Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
    Figure 52. Abbott Laboratories Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
    Figure 53. Burning Rock Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
    Figure 54. Novogene Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
    Figure 55. Geneseeq Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
    Figure 56. Amoy Diagnostics Co.,Ltd. Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
    Figure 57. Daan Gene Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
    Figure 58. Fosun Pharma Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2019-2024)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS